Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
How to buy Infinity Pharmaceuticals stock
Learn how to easily invest in Infinity Pharmaceuticals stock.
Infinity Pharmaceuticals is a biotechnology business based in the US. Infinity Pharmaceuticals shares (INFI) are listed on the NASDAQ and all prices are listed in US Dollars.
How to buy Infinity Pharmaceuticals stock
- Open a stock trading account. Use our comparison table or choose from our Top Picks.
- Confirm your payment details. Fund your account with a bank transfer, debit card or credit card and take advantage of any signup bonuses.
- Search for the stock by name or ticker symbol – INFI. It's that simple.
- Trade stocks for $0 and no annual fee
- Start trading with a $0 minimum deposit
- Get up to $1,000 when you fund a new account within 30 days
- Trade stocks and ETFs for $0 and no annual fee
- Minimum deposit of $10 required
- FINDER EXCLUSIVE: Get $15 when you sign up and deposit $100
- Get free stock upon signup
- Earn 4% interest on uninvested cash with Robinhood Gold
- Get 1% match on contributions to a Robinhood IRA
Infinity Pharmaceuticals stock price (NASDAQ: INFI)Use our graph to track the performance of INFI stocks over time.
Infinity Pharmaceuticals shares at a glance
|Latest market close||$0.64|
|52-week range||$0.44 - $1.76|
|50-day moving average||$0.58|
|200-day moving average||$0.87|
|Wall St. target price||$5.33|
|Dividend yield||$0 (0%)|
|Earnings per share (TTM)||$-0.52|
Buy Infinity Pharmaceuticals stocks from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
Information on this page is for educational purposes only. Finder is not an advisor or brokerage service, and we don't recommend investors to trade specific stocks or other investments.
Finder is not a client of any featured partner. We may be paid a fee for referring prospective clients to a partner, though it is not a recommendation to invest in any one partner.
Is it a good time to buy Infinity Pharmaceuticals stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Infinity Pharmaceuticals price performance over time
|1 week (2023-01-27)||-0.75%|
|1 month (2023-01-03)||11.44%|
|3 months (2022-11-03)||-47.93%|
|6 months (2022-08-03)||-10.03%|
|1 year (2022-01-30)||N/A|
|2 years (2021-02-03)||-82.83%|
|3 years (2020-02-03)||1.29|
|5 years (2018-02-02)||2.01|
Infinity Pharmaceuticals financials
|Revenue TTM||$2.5 million|
|Gross profit TTM||$-30,909,000|
|Return on assets TTM||-40.02%|
|Return on equity TTM||-439.96%|
|Market capitalisation||$56.8 million|
TTM: trailing 12 months
Infinity Pharmaceuticals share dividends
We're not expecting Infinity Pharmaceuticals to pay a dividend over the next 12 months.
Have Infinity Pharmaceuticals's shares ever split?
Infinity Pharmaceuticals's shares were split on a 1:4 basis on 12 September 2006. So if you had owned 4 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Infinity Pharmaceuticals shares – just the quantity. However, indirectly, the new 300% higher share price could have impacted the market appetite for Infinity Pharmaceuticals shares which in turn could have impacted Infinity Pharmaceuticals's share price.
Infinity Pharmaceuticals share price volatility
Over the last 12 months, Infinity Pharmaceuticals's shares have ranged in value from as little as $0.44 up to $1.76. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Infinity Pharmaceuticals's is 1.2347. This would suggest that Infinity Pharmaceuticals's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).
Infinity Pharmaceuticals overview
Infinity Pharmaceuticals, Inc. , a biopharmaceutical company, focuses on developing novel medicines for people with cancer. Its product candidate is IPI-549, an orally administered clinical-stage immuno-oncology product candidate that inhibits the enzyme phosphoinositide-3-kinase-gamma, which is in Phase 2 clinical trials for the treatment of metastatic triple negative breast cancer and urothelial cancer; and Phase 1/1b clinical trials for the treatment of solid tumors. The company has strategic alliances with Intellikine, Inc. to discover, develop, and commercialize pharmaceutical products targeting the delta and/or gamma isoforms of PI3K; Verastem, Inc. to research, develop, commercialize, and manufacture duvelisib and products containing duvelisib; and PellePharm, Inc. to develop and commercialize rights to its hedgehog inhibitor program, IPI-926, a clinical-stage product candidate, as well as collaboration agreements with Arcus Biosciences, Inc.
Frequently asked questionsWhat percentage of Infinity Pharmaceuticals is owned by insiders or institutions?
Currently 1.25% of Infinity Pharmaceuticals shares are held by insiders and 35.689% by institutions. When does the fiscal year end for Infinity Pharmaceuticals?
Infinity Pharmaceuticals's fiscal year ends in December. Where is Infinity Pharmaceuticals based?
Infinity Pharmaceuticals's address is: 1100 Massachusetts Avenue, Cambridge, MA, United States, 02138 What is Infinity Pharmaceuticals's ISIN number?
Infinity Pharmaceuticals's international securities identification number is: US45665G3039 What is Infinity Pharmaceuticals's CUSIP number?
Infinity Pharmaceuticals's Committee on Uniform Securities Identification Procedures number is: 254675101
More guides on Finder
How to buy Neuraxis (NRXS) stock when it goes public
Everything we know about the Neuraxis IPO, plus information on how to buy in.
How to buy TXO Energy (TXO) stock
Everything we know about the TXO Energy IPO, plus information on how to buy in.
How to buy Brera (BREA) stock
Everything we know about the Brera IPO, plus information on how to buy in.
How to invest in the S&P 500
What you need to know about investing in the leading indicator for the overall US stock market.
How to buy IPO stock
Buying an IPO is as simple as buying any other stock, but not every trading platform offers IPO stocks.
How to buy Novo Integrated Sciences stock
Steps to owning and managing NVOS, with 24-hour and historical pricing before you buy.
How do ETFs work?
Your simple and straightforward guide to ETFs, how they work and the different types available.
What is stock lending?
Find out how stock lending works, the extra income you could potentially earn and the risks you should be aware of. Plus, compare stock trading platforms that offer stock lending.
How to buy SONDORS (SODR) stock when it goes public
Everything we know about the SONDORS IPO, plus information on how to buy in.
How to buy Bullfrog AI Holdings (BFRG) stock when it goes public
Everything we know about the Bullfrog AI Holdings IPO, plus information on how to buy in.
Ask an Expert